CAMBRIDGE, Mass., December 06, 2021--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, ...
News
- Infinity Pharmaceuticals to Host an Investor Event on Updated MARIO-3 Data ... - Yahoo Finance
- $1.2M awarded for Alabama-based breast cancer research - mySA
San Antonio should reconsider those 'Edgar' haircut jokes ... CerFlux, Southern Research and the HudsonAlpha Institute for Biotechnology.
- $1.2M awarded for Alabama-based breast cancer research - San Antonio Express-News
... the University of South Alabama, the University of Alabama, CerFlux, Southern Research and the HudsonAlpha Institute for Biotechnology.
- Infinity Pharmaceuticals to Host an Investor Event on Updated MARIO-3 Data Presented at ...
... a clinical-stage biotechnology company developing eganelisib, ... MARIO-3 Data Presented at the 2021 San Antonio Breast Cancer Symposium.
- Scientists use stem cells to create models of pre-embryos | WOAI
... "blastoids" provide an efficient, ethical way to study human development and pursue biomedical discoveries in fertility and contraception.